Romosozumab for the treatment of severe osteoporosis
Sign Up to like & getrecommendations! Published in 2020 at "Prescriber"
DOI: 10.1002/psb.1851
Abstract: Romosozumab (Evenity) is a new monoclonal antibody therapy for severe osteoporosis in postmenopausal women at high risk of fracture. This article outlines its indications, clinical trial efficacy and side‐effects. read more here.
Keywords: romosozumab treatment; treatment severe; osteoporosis; severe osteoporosis ... See more keywords
Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk
Sign Up to like & getrecommendations! Published in 2022 at "Women's Health"
DOI: 10.1177/17455057221125577
Abstract: Increased understanding of the Wnt signaling pathway has led to the development of romosozumab, one of the most potent osteoanabolic agents to date for osteoporosis treatment. Romosozumab is a monoclonal antibody that inhibits sclerostin, a… read more here.
Keywords: romosozumab; osteoporosis; risk; cardiovascular risk ... See more keywords